Home › Acute Lymphoblastic Leukemia › Florida › Gainesville
Acute Lymphoblastic Leukemia clinical trials in Gainesville, FL
4 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in and around Gainesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
RecruitingPhase 1/2Healthy volunteers welcome
- University of Florida, Gainesville
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- UF Health Cancer Institute - Gainesville, Gainesville
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- University of Florida Shands Medical Center, Gainesville
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
RecruitingPhase 2
- University of Florida, Gainesville
Acute Lymphoblastic Leukemia trials in other cities
- Houston, TX28 studies
- New York City, NY24 studies
- Seattle, WA21 studies
- Baldwin Park, CA21 studies
- Chicago, IL19 studies
- Atlanta, GA18 studies
- Memphis, TN16 studies
- Washington, DC16 studies
- Philadelphia, PA16 studies
- Boston, MA15 studies
- Los Angeles, CA14 studies
- Mountain View, CA13 studies
Other studies in Gainesville
- Heart Failure13 studies
- Parkinson's Disease13 studies
- Type 1 Diabetes12 studies
- Breast Cancer12 studies
- Non-Small Cell Lung Cancer10 studies
- Colorectal Cancer9 studies
- Cardiovascular Disease9 studies
- Cancer (all types)9 studies
- Lung Cancer9 studies
- Prostate Cancer8 studies
- Mild Cognitive Impairment8 studies
- Acute Myeloid Leukemia8 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.